Connect Biopharma Holdings Ltd - ADR (CNTB) Stock Price

3.19 ▲ +0.06 (+1.92%)
Open: 3.19 Vol: 0 Day's range: 3.19 - 3.19 Mar 25, 09:46 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CNTB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.18▲ 3.13▲ 3.09▲ 2.99▲ 2.73▲
MA10 3.14▲ 3.04▲ 3.01▲ 2.86▲ 2.62▲
MA20 3.08▲ 2.95▲ 2.90▲ 2.73▲ 2.55▲
MA50 2.95▲ 2.83▲ 2.81▲ 2.60▲ 1.87▲
MA100 2.85▲ 2.83▲ 2.74▲ 2.47▲ 1.53▲
MA200 2.83▲ 2.71▲ 2.67▲ 2.05▲ 1.31▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.009▲ 0.029▲ 0.032▲ 0.047▲ 0.026▲
RSI 73.158▲ 75.306▲ 72.957▲ 65.954▲ 66.950▲
STOCH 87.037▲ 92.914▲ 85.681▲ 71.877     58.961    
WILL %R 0.000▲ 0.000▲ 0.000▲ 0.000▲ 0.000▲
CCI 154.406▲ 154.550▲ 195.616▲ 193.795▲ 205.422▲
Latest Filters Detected On CNTB
▲ BREAK $CNTB Price Breaks 60 Days High Set Alert
▲ BREAK $CNTB Price Breaks 30 Days High Set Alert
▲ BREAK $CNTB Price Breaks 20 Days High Set Alert
▲ BREAK $CNTB Price Breaks 10 Days High Set Alert
Connect Biopharma Holdings Ltd - ADR News
Connect Biopharma Touts “Next-Gen Dupixent” Rademikibart, Near-Term Asthma/COPD Readouts
Saturday, March 14, 2026 07:35 AM
CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners ...
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of ...
Tuesday, March 10, 2026 06:29 AM
Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of ...
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
Tuesday, March 03, 2026 01:00 AM
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused ...
CNTB historical stock data
date open high low close volume
25/03/26 3.19 3.225 3.18 3.225 54,021
24/03/26 3.01 3.16 2.88 3.13 376,253
23/03/26 2.81 2.98 2.76 2.95 222,933
20/03/26 2.79 2.88 2.69 2.76 112,541
19/03/26 2.85 3.00 2.78 2.87 171,193
18/03/26 2.72 2.78 2.5614 2.72 157,333
17/03/26 2.73 2.8006 2.665 2.71 18,658
16/03/26 2.68 2.8425 2.56 2.70 136,513
13/03/26 2.81 3.03 2.67 2.69 66,762
12/03/26 3.01 3.02 2.77 2.80 54,515
Quote Details
52wk Low:0.51
52wk High:3.28
Vol:0
Avg Vol(3m):2M
1Y Chng:+404.85%
1M Chng:+20.34%
Add to Watch List
More Information
Index US Composite
Market Cap. 164.92M